Metraipolis › archive › dc_f5c48ff930ee

Targeting immunoglobulin superfamily member 9 (IGSF9) to overcome acute myeloid leukemia resistance to CAR-T therapy — Europe PMC PMID:42157270

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42157270
DOI: 10.1186/s13046-[numero omesso]-4
License (as archived): solo-consultazione
Archived: 2026-11-01T14:34:48.219Z
SHA-256 of the archived text: c62966ee599a969b3ba1a36ed18878ef34f342e012ea17d7a9aa9adb8b827389
Stable URL of this page: https://metraipolis.com/documento/dc_f5c48ff930ee

How to cite

Targeting immunoglobulin superfamily member 9 (IGSF9) to overcome acute myeloid leukemia resistance to CAR-T therapy — Europe PMC PMID:42157270 — Europe PMC (en), https://europepmc.org/article/MED/42157270 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f5c48ff930ee (Metraipolis archive dc_f5c48ff930ee, sha256 c62966ee599a969b3ba1a36ed18878ef34f342e012ea17d7a9aa9adb8b827389)

BibTeX

@misc{dcf5c48ff930ee,
  title = {Targeting immunoglobulin superfamily member 9 (IGSF9) to overcome acute myeloid leukemia resistance to CAR-T therapy — Europe PMC PMID:42157270},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42157270},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f5c48ff930ee; sha256 c62966ee599a969b3ba1a36ed18878ef34f342e012ea17d7a9aa9adb8b827389},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42157270. Agents can read the archived copy with the MCP tool read_document.